Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy

LK Mell, JD Kochanski, JC Roeske, JJ Haslam… - International Journal of …, 2006 - Elsevier
Purpose: To identify dosimetric parameters associated with acute hematologic toxicity (HT)
and chemotherapy delivery in cervical cancer patients undergoing concurrent chemotherapy …

Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study

HD Homesley, BN Bundy, JA Hurteau, LM Roth - Gynecologic oncology, 1999 - Elsevier
Objectives. The objectives of this study were to assess efficacy and toxicity of the
combination of bleomycin, etoposide, and cisplatin (BEP) in this Phase II trial as first-line …

A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery

JM Schilder, JA Hurteau, KY Look, DH Moore… - Gynecologic …, 1997 - Elsevier
Objective. The objective was to determine whether, when compared with traditional dietary
advancement, early oral intake following major gynecologic surgery leads to a reduction in …

Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients

MA Schroder, LK Mell, JA Hurteau, YC Collins… - International Journal of …, 2005 - Elsevier
PURPOSE: The purpose of this pilot study was to evaluate the efficacy of the clitoral therapy
device (Eros Therapy) in alleviating sexual dysfunction in irradiated cervical cancer patients …

Evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group study

JA Hurteau, JA Blessing, SL DeCesare… - Gynecologic …, 2001 - Elsevier
Objective. The goal of this study was to estimate the antitumor activity and toxicity of
recombinant human interleukin-12 (rhIL-12) in patients with recurrent or refractory epithelial …

Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas

JR Wiener, JA Hurteau, BJM Kerns, RS Whitaker… - American journal of …, 1994 - Elsevier
OBJECTIVE: Our purpose was to determine whether protein tyrosine phosphatase 1B is
overexpressed in ovarian cancers, possibly altering the balance of intracellular tyrosine …

The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer

LE Weinberg, G Rodriguez… - Journal of surgical …, 2010 - Wiley Online Library
The current management of advanced ovarian cancer consists of aggressive primary
cytoreductive surgery (PCS) followed by combination platinum based chemotherapy. Recent …

Gestational trophoblastic disease: management of hydatidiform mole

JA Hurteau - Clinical obstetrics and gynecology, 2003 - journals.lww.com
Gestational trophoblastic disease (GTD) defines a neoplastic process that is derived from
fetal chorion during pregnancy. It includes a spectrum of disease comprising molar …

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma …

JA Hurteau, MF Brady, KM Darcy, WP McGuire… - Gynecologic …, 2010 - Elsevier
PURPOSE: To compare progression-free survival (PFS), overall survival (OS) and toxicities
of thalidomide versus tamoxifen and to evaluate serum vascular endothelial growth factor …

Gynecologic cancers metastatic to the breast

DH Moore, DK Wilson, JA Hurteau, KY Look… - Journal of the American …, 1998 - Elsevier
Background: We report a series of gynecologic cancers metastatic to the breast, illustrating
the diagnostic and prognostic implications of this rare event. Study Design: By reviewing the …